Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cortisone therapy today].

Hanns Kaiser

    Wiener Klinische Wochenschrift
    |March 28, 2003
    PubMed
    Summary
    This summary is machine-generated.

    Modern corticoid (corticosteroid) therapy utilizes genomic and non-genomic effects for anti-inflammatory action. Optimized dosing and application minimize adverse effects, making corticosteroids effective for rheumatoid arthritis and asthma management.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same journal

    [Vaccination of immunocompromised individuals: Expert opinion - update 2026].

    Wiener klinische Wochenschrift·2026
    Same journal

    Systematic review of clinical evidence for Kneipp medicine.

    Wiener klinische Wochenschrift·2026
    Same journal

    Pelvic resections in primary sarcomas : Surgical outcomes and survival analysis of 75 patients.

    Wiener klinische Wochenschrift·2026
    Same journal

    Jungmediziner*innen am Start: 11. Workshop für den medizinischen Nachwuchs.

    Wiener klinische Wochenschrift·2026
    Same journal

    Stellungnahme der ÖGP zur geplanten Gesetzesnovelle zum Nichtraucherschutzgesetz.

    Wiener klinische Wochenschrift·2026
    Same journal

    MUW researcher of the month: Dr. Moritz Schaefer.

    Wiener klinische Wochenschrift·2026

    Area of Science:

    • Pharmacology
    • Immunology
    • Rheumatology

    Context:

    • Corticosteroid therapy has evolved over five decades.
    • Understanding genomic and non-genomic mechanisms is crucial.
    • Adverse effects are minimized with modern therapeutic strategies.

    Purpose:

    • To review the dual modes of action of corticosteroids (genomic and non-genomic).
    • To outline optimized dosing and application strategies for improved safety and efficacy.
    • To highlight the renewed use of corticosteroids in treating rheumatoid arthritis and asthma.

    Summary:

    • Corticosteroids exert anti-inflammatory effects via genomic (late-onset, protein-mediated) and non-genomic (rapid, membrane-mediated) pathways.
    • Modern regimens involve high-dose short-term therapy for acute conditions and very low-dose long-term therapy (≤5 mg prednisolone daily) for chronic illnesses.

    Related Experiment Videos

  • Osteoporosis prophylaxis is mandatory in long-term therapy. Topical applications are preferred when possible.

    • Impact:

    • Low-dose corticosteroid therapy offers a safer alternative to nonsteroidal anti-inflammatory drugs for rheumatoid arthritis, significantly inhibiting joint destruction.
    • Corticosteroids are now integral to long-term asthma management through specialized topical applications, expanding their therapeutic role beyond acute systemic treatment.